IL-6R; IL-23p19
授权管线 · — · —
授权管线Confidentiality：公开
- INN / Generic Name
- IL-6R; IL-23p19
- Dosage Form
- —
- Strength
- —
- Therapy Area
- Immunology & Inflammation
- Indication
- Inflammatory bowel disease; Psoriasis; Rheumatoid arthritis; Systemic lupus erythematosus
- Current Status
- 新药候选授权（UB344）· 临床前（Preclinical）
- GMP Certification
- —
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- 授权 / 共同开发（视靶点与阶段）
- MOQ
- 1 个项目
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —